Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

30.0%

3 terminated/withdrawn out of 10 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
10(100.0%)
10Total
N/A(10)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06217328Not ApplicableActive Not Recruiting

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Role: lead

NCT03596671Not ApplicableCompleted

BlueWind RENOVA iStim™ System for the Treatment of OAB

Role: lead

NCT04243902Not ApplicableWithdrawn

Urinary Catheter 'Fill and Flush' Valve: Safety, Effectiveness, Acceptability and Feasibility Trial

Role: collaborator

NCT02062398Not ApplicableCompleted

BlueWind Medical Reprieve System for the Treatment of PNP

Role: lead

NCT02299544Not ApplicableCompleted

BlueWind Medical System for the Treatment of Patients With OAB

Role: lead

NCT03448861Not ApplicableUnknown

CHroniSense National Early Warning Score Study

Role: lead

NCT02209896Not ApplicableCompleted

BlueWind Reprieve System for the Treatment of PNP

Role: lead

NCT02777216Not ApplicableCompleted

ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves

Role: lead

NCT01940406Not ApplicableWithdrawn

The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study

Role: lead

NCT03019094Not ApplicableWithdrawn

Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1

Role: lead

All 10 trials loaded